Previous Article | Next Article 
Infection and Immunity, December 2003, p. 6830-6834, Vol. 71, No. 12
0019-9567/03/$08.00+0 DOI: 10.1128/IAI.71.12.6830-6834.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
The Site of Leishmania major Infection Determines Disease Severity and Immune Responses
Tracey M. Baldwin, Colleen Elso, Joan Curtis, Lynn Buckingham, and Emanuela Handman*
The
Walter and Eliza Hall Institute of Medical Research, Melbourne,
Australia
Received 9 June 2003/
Returned for modification 2 August 2003/
Accepted 30 August 2003
Inbred
strains of mice infected with Leishmania major have been
classified as genetically resistant or susceptible on the basis of
their ability to cure their lesions, the parasite burden in the
draining lymph nodes, and their type of T helper cell immune responses
to the parasite. Using the intradermal infection at the base of the
tail and the ear pinna, we compared for the first time the
above-mentioned parameters in six strains of mice infected with
metacyclic promastigotes, and we show that the severity of disease
depends greatly on the site of infection. Although the well-documented
pattern of disease susceptibility of BALB/c and C57BL/6 mice described
for the footpad and base-of-the-tail models of leishmaniasis were
confirmed, C3H/HeN and DBA/2 mice, which are intermediate and
susceptible, respectively, in the tail and other models, were resistant
to ear infection. Moreover, in the CBA/H, C3H/HeN, C57BL/6J, and DBA/2
mouse strains, there was little correlation between the pattern of
cytokines produced and the disease phenotype observed at the ear and
tail sites. We conclude that the definition of susceptibility and the
immune mechanisms leading to susceptibility or resistance to infection
may differ substantially depending on the route of
infection.
* Corresponding
author. Mailing address: The Walter and Eliza Hall Institute of Medical
Research, 1G Royal Parade, Parkville, Victoria 3050, Australia. Phone:
61-3-9345-2476. Fax: 61-3-9347-0852. E-mail:
handman{at}wehi.edu.au.
Editor:
W. A. Petri, Jr.
Infection and Immunity, December 2003, p. 6830-6834, Vol. 71, No. 12
0019-9567/03/$08.00+0 DOI: 10.1128/IAI.71.12.6830-6834.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Carter, C. R., Whitcomb, J. P., Campbell, J. A., Mukbel, R. M., McDowell, M. A.
(2009). Complement Receptor 3 Deficiency Influences Lesion Progression during Leishmania major Infection in BALB/c Mice. Infect. Immun.
77: 5668-5675
[Abstract]
[Full Text]
-
Duthie, M. S., Reece, S. T., Lahiri, R., Goto, W., Raman, V. S., Kaplan, J., Ireton, G. C., Bertholet, S., Gillis, T. P., Krahenbuhl, J. L., Reed, S. G.
(2007). Antigen-Specific Cellular and Humoral Responses Are Induced by Intradermal Mycobacterium leprae Infection of the Mouse Ear. Infect. Immun.
75: 5290-5297
[Abstract]
[Full Text]
-
Rosas, L. E., Keiser, T., Barbi, J., Satoskar, A. A., Septer, A., Kaczmarek, J., Lezama-Davila, C. M., Satoskar, A. R.
(2005). Genetic background influences immune responses and disease outcome of cutaneous L. mexicana infection in mice. Int Immunol
17: 1347-1357
[Abstract]
[Full Text]
-
de Moura, T. R., Novais, F. O., Oliveira, F., Clarencio, J., Noronha, A., Barral, A., Brodskyn, C., de Oliveira, C. I.
(2005). Toward a Novel Experimental Model of Infection To Study American Cutaneous Leishmaniasis Caused by Leishmania braziliensis. Infect. Immun.
73: 5827-5834
[Abstract]
[Full Text]
-
Tabbara, K. S., Peters, N. C., Afrin, F., Mendez, S., Bertholet, S., Belkaid, Y., Sacks, D. L.
(2005). Conditions Influencing the Efficacy of Vaccination with Live Organisms against Leishmania major Infection. Infect. Immun.
73: 4714-4722
[Abstract]
[Full Text]
-
Baldwin, T., Henri, S., Curtis, J., O'Keeffe, M., Vremec, D., Shortman, K., Handman, E.
(2004). Dendritic Cell Populations in Leishmania major-Infected Skin and Draining Lymph Nodes. Infect. Immun.
72: 1991-2001
[Abstract]
[Full Text]